Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Diagnosing simple-virilizing congenital adrenal hyperplasia can be difficult and requires thorough testing and expert advice.

3D printed alginate-gelatin hydrogels are promising for drug delivery and testing treatments for diseases like Alzheimer's.

Strat-M® membrane can effectively replace mouse skin for testing collagen peptide delivery.

Men with low or no sperm count have lower salivary testosterone levels, and saliva testing can measure their testosterone well.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

A new method quickly creates controllable cell clusters for tissue engineering and drug testing.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

Sebum samples remain stable under various storage conditions, making them suitable for remote and at-home testing.

An 11-year-old Greek girl was diagnosed with a rare genetic disorder, highlighting the importance of genetic testing and family history.

The photographic method for measuring facial hair density is reliable and valid but needs further testing on different hair densities and skin colors.

The MEST method increases cell yield and volume for regenerative medicine but needs more testing.

Scientists created a 3D skin model to study a chronic skin disease and test treatments.

PP-PTKL may help treat hair greying, but more testing is needed.

Human hair follicle organ culture is a useful model for hair research with potential for studying hair biology and testing treatments.

The article concludes that developing in vitro models for human hair structures is important for research and reducing animal testing, but there are challenges like obtaining suitable samples and the models' limitations.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

A low-cost, 3D-printed light therapy device is safe and effective but needs more testing before use on people.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Canine hypothyroidism can be linked to diabetes, requiring thorough testing for proper diagnosis.

Topical glutamic acid may help hair regrow after burns, but more human testing is needed.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Biopsy can differentiate between alopecia areata and androgenic alopecia, and if more information is needed, testing for CD3 and CD8 can help.

A child has a rare hair and skin disorder due to specific gene variants, suggesting broader genetic testing is needed.

Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.

Early phosphorus-calcium disorders in children with chronic kidney disease can lead to bone issues, highlighting the need for early bone density testing.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Organoid technology helps create mini-organs for studying diseases and testing drugs.

Exosomes from mesenchymal stem cells show promise for tissue repair but face challenges in isolation and safety testing.

Ludwig pattern hair loss in women results from varying sensitivity in hair follicles, causing fewer visible hairs.